AAC $10.11 +0.10% ▲ ACHR $5.47 -1.08% ▼ AERO $14.75 -4.72% ▼ AIN $59.47 -1.25% ▼ AIR $115.92 -3.46% ▼ AM $21.33 -2.65% ▼ AMP $559.34 +0.15% ▲ AMTM $20.14 +2.03% ▲ APH $77.65 -1.52% ▼ ASB $30.04 -1.01% ▼ ATI $198.77 -0.12% ▼ ATRO $73.98 +0.67% ▲ AVAV $146.71 -0.75% ▼ AVNW $19.05 -3.30% ▼ AXON $490.00 -3.35% ▼ BAB $26.17 -0.34% ▼ BAH $72.20 +0.12% ▲ BBAI $2.83 -3.69% ▼ BDL $46.00 +1.34% ▲ BELFB $246.01 -0.71% ▼ BHE $74.39 +0.64% ▲ BKSY $21.61 -3.06% ▼ BWXT $156.71 -2.56% ▼ CACI $606.85 -2.95% ▼ CAE $24.06 -0.91% ▼ CDRE $29.12 -1.82% ▼ CICN $0.00 CMTL $1.53 -6.30% ▼ CNC $64.06 -1.43% ▼ CODA $10.01 -0.89% ▼ AAC $10.11 +0.10% ▲ ACHR $5.47 -1.08% ▼ AERO $14.75 -4.72% ▼ AIN $59.47 -1.25% ▼ AIR $115.92 -3.46% ▼ AM $21.33 -2.65% ▼ AMP $559.34 +0.15% ▲ AMTM $20.14 +2.03% ▲ APH $77.65 -1.52% ▼ ASB $30.04 -1.01% ▼ ATI $198.77 -0.12% ▼ ATRO $73.98 +0.67% ▲ AVAV $146.71 -0.75% ▼ AVNW $19.05 -3.30% ▼ AXON $490.00 -3.35% ▼ BAB $26.17 -0.34% ▼ BAH $72.20 +0.12% ▲ BBAI $2.83 -3.69% ▼ BDL $46.00 +1.34% ▲ BELFB $246.01 -0.71% ▼ BHE $74.39 +0.64% ▲ BKSY $21.61 -3.06% ▼ BWXT $156.71 -2.56% ▼ CACI $606.85 -2.95% ▼ CAE $24.06 -0.91% ▼ CDRE $29.12 -1.82% ▼ CICN $0.00 CMTL $1.53 -6.30% ▼ CNC $64.06 -1.43% ▼ CODA $10.01 -0.89% ▼

Nurses Press Hospitals to Reconsider Palantir Partnerships Amid Public Controversy

September 11, 2026 · by DPW Pipeline

Nurses Press Hospitals to Reconsider Palantir Partnerships Amid Public Controversy

A campaign by nurses across the United States is calling on hospital systems to end their relationships with Palantir Technologies Inc., according to reporting by Truthout. The organizing effort cites concerns over the data analytics company’s work with U.S. Immigration and Customs Enforcement (ICE) and its involvement connected to the conflict in Gaza.

Palantir, a Colorado-based software firm, is best known for building large-scale data platforms used by government agencies. Its Palantir Gotham platform integrates data sources for users in the intelligence and defence communities, and the company also sells commercial products to healthcare organizations, including tools for hospital operations and data management. That dual footprint — serving both public-sector defence clients and private healthcare providers — has placed the company at the center of activism within the medical community.

The nurse-led campaign reflects a broader pattern of public scrutiny facing defence-adjacent technology firms whose commercial products reach civilian institutions. Hospitals that contract with such vendors increasingly face questions from staff and patient advocates about the downstream implications of those business relationships, even when the healthcare engagements themselves are operationally separate from government work.

For investors tracking the company, the activism arrives amid a period of significant commercial expansion. Palantir Technologies Inc. (PLTR) traded at $170.50 recently, down 0.07% from a previous close of $170.62, with a market capitalization of roughly $439.7 billion. The stock is classified in the Technology sector under the Software — Infrastructure industry.

Palantir has not announced any change to its healthcare contracts in response to the campaign, and the companies’ hospital clients have not publicly indicated they are reviewing those agreements. It remains unclear how many institutions are the target of the nurses’ demands or what specific contracts are at issue.

Healthcare worker activism of this kind has historically focused on issues ranging from supply chains to data privacy. Campaigns targeting defence-sector vendors represent a newer dimension, as software firms with government portfolios expand into commercial markets where their brand recognition — and the scrutiny that comes with it — carries over.

What to watch

  • Whether any hospital systems publicly address or review their Palantir contracts in response to the campaign.
  • Palantir’s upcoming quarterly earnings report and any commentary on commercial healthcare revenue.
  • Further reporting on the scope of the nurses’ organizing effort and any formal petitions filed.
  • Any company statements regarding its government and healthcare business lines.

Source: original release